Sadr, Ahmad Shahir http://orcid.org/0000-0001-7932-5251
Abdollahpour, Zahra
Aliahmadi, Atousa http://orcid.org/0000-0002-1723-3914
Eslahchi, Changiz http://orcid.org/0000-0002-8913-3904
Nekouei, Mina
Kiaei, Lily
Kiaei, Mahmoud http://orcid.org/0000-0002-0802-1426
Ghassempour, Alireza http://orcid.org/0000-0002-6435-9915
Article History
Received: 14 January 2021
Accepted: 6 June 2021
First Online: 24 July 2021
Declarations
:
: Dr. Kiaei is the founder, President and CEO of RockGen Therapeutics, LLC., and have a financial interest in the technology discussed in this publication. These financial interests have been reviewed and approved in accordance with the RockGen conflict of interest policies. Other authors have no conflict.
: There were no human participants or animals used in this study.
: N/A.
: This article does not contain any studies with human participants or animals performed by any of the authors.